Literature DB >> 2884934

Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.

R N Hobbs, A L Clayton, R M Bernstein.   

Abstract

Certain drugs are a frequent source of antinuclear antibody (ANA) induction, and ANA is invariably present in the few patients who progress to the drug induced lupus syndrome. This report concerns the fine specificity of the ANA response to hydralazine, penicillamine, and sulphasalazine therapy. Using highly purified individual histones in fluorimetric assays, antihistone antibodies are always detectable, often in large amounts, but the pattern of response to individual histones is variable and not drug specific. In addition to the response to the three histones H1, H2B, and H3 reminiscent of idiopathic systemic lupus erythematosus, antibody to histone H2A predominates in some drug induced cases. Contrary to previous thought, histones are not the sole target of the antinuclear response: we also demonstrate a significant correlation between ANA titre and antibody to poly(adenosine diphosphate-ribose). Like the histones, this is a macromolecule that can bind to deoxyribonucleic acid (DNA). It is proposed that drug induced damage to chromatin leads to ANA production, while drug induced impairment of complement activity may then enable these autoantibodies to mediate the lupus syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884934      PMCID: PMC1002151          DOI: 10.1136/ard.46.5.408

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  35 in total

Review 1.  The role of complement and its receptor in the elimination of immune complexes.

Authors:  J A Schifferli; Y C Ng; D K Peters
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

2.  Measurement of serum DNA-binding activity in systemic lupus erythematosus.

Authors:  T Pincus; P H Schur; J A Rose; J L Decker; N Talal
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

3.  Reactivity of anti-histone antibodies induced by procainamide and hydralazine.

Authors:  J P Portanova; R L Rubin; F G Joslin; V D Agnello; E M Tan
Journal:  Clin Immunol Immunopathol       Date:  1982-10

4.  Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B.

Authors:  J A Hardin; J O Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

5.  The lupus syndrome induced by hydralazine: a common complication with low dose treatment.

Authors:  H A Cameron; L E Ramsay
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

6.  Drugs that induce systemic lupus erythematosus inhibit complement component C4.

Authors:  E Sim; E W Gill; R B Sim
Journal:  Lancet       Date:  1984-08-25       Impact factor: 79.321

7.  A fluorimetric assay for human antibodies to all the histones.

Authors:  R N Hobbs; D J Lea; D J Ward
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

8.  IgG antibodies to the histone complex H2A-H2B characterize procainamide-induced lupus.

Authors:  R L Rubin; E M McNally; S R Nusinow; C A Robinson; E M Tan
Journal:  Clin Immunol Immunopathol       Date:  1985-07

9.  Binding of isolated rheumatoid factors to histone proteins and basic polycations.

Authors:  R N Hobbs; D J Lea; K K Phua; P M Johnson
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

10.  The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus.

Authors:  A Epstein; P Barland
Journal:  Arthritis Rheum       Date:  1985-02
View more
  8 in total

1.  Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.

Authors:  M M Gordon; D R Porter; H A Capell
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

Review 2.  Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones.

Authors:  A M Leak; P Woo
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

3.  Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin.

Authors:  R W Burlingame; R L Rubin
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

Review 4.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

5.  Identification of antihistone antibodies in subsets of juvenile chronic arthritis.

Authors:  M Ostensen; K Fredriksen; E Kåss; O P Rekvig
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

6.  Individual variation in the isotype profile of anti-histone autoantibodies in systemic lupus erythematosus.

Authors:  G Fellows; N Gittoes; D G Scott; J S Coppock; A Wainwright; M Goodall; B M Turner
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

Review 7.  Drug-induced rheumatic syndromes. Diagnosis, clinical features and management.

Authors:  M G Cohen; M V Prowse
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 May-Jun

8.  Hydralazine-induced lupus erythematosis.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12-09       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.